<DOC>
	<DOCNO>NCT00941382</DOCNO>
	<brief_summary>The aim study evaluate effect sibutramine metformin combination therapy comparison sibutramine metformin monotherapy weight , adiposity , glucose metabolism inflammatory state obese patient .</brief_summary>
	<brief_title>Sibutramine-metformin Combination Versus Sibutramine Metformin Monotherapy Obese Patients</brief_title>
	<detailed_description>The treatment obesity strongly recommend exacerbates insulin resistance , hypertension , dyslipidemia atherosclerosis , represent risk factor type 2 diabetes . Although diet exercise valuable treatment , patient compliance major problem . Sibutramine show highly effective pharmacotherapy weigh loss obese patient , mediate increase satiety enhancement energy expenditure . Metformin widely use glycemia control associate small moderate body weight loss . We assess combination sibutramine metformin , two agent different mechanisms action control body weight metabolic dysregulation .</detailed_description>
	<mesh_term>Metformin</mesh_term>
	<mesh_term>Sibutramine</mesh_term>
	<criteria>Inclusion criterion Age 30 50 year Both gender BMI 30 40 Stable body weigh define 5 per cent variability previous 3 month Fasting serum glucose le 126 mg per dl Blood pressure 140 90 mmHg Women ensure contraceptive precaution . Communication understanding capability . Informed consent award . Exclusion criterion Women exclude pregnant lactate potential take adequate contraceptive precaution Any smoke precede 6 month No physical activity , define less 15 minute per day walk Excessive physical activity equivalent run 60 minute per day Known hypersensitivity sibutramine metformin Low commitment follow protocol statement Any investigational medication precede 6 month Any drug substance mayor toxicity exposure precede 3 month Alcohol drug abuse previous 3 month Current medication oral corticosteroid , anticoagulant , sympathomimetics , sympatholytics , lipid lower drug , medication type 2 diabetes , sibutramine interaction drug Current previous evidence ischemic heart disease , cardiac arrhythmia , cerebrovascular disease , chronic hepatic disease , two fold persistent elevation ALT , AST FA Carrying pacemaker permanent bioelectronic component could interfere bioimpedance process Renal failure define serum creatinine equal ever 1.2 mg per dL Not control thyroid disease define altered serum T3 , T4 TSH previous 3 month Hypertension Type 2 diabetes Antidepressants , psychiatric disturbance treatment</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>July 2009</verification_date>
	<keyword>sibutramine</keyword>
	<keyword>metformin</keyword>
	<keyword>obesity</keyword>
</DOC>